June 3, 2020

US Bioservices now dispenses ZEPOSIA® (ozanimod)

ZEPOSIA® (ozanimod) is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.